Patents by Inventor I-Lin Lin

I-Lin Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PRETREATMENT METHOD AND SYSTEM FOR APPLICATION OF COATING TO SHOE PARTS
    Publication number: 20150328660
    Abstract: A pretreatment method for application of coating to shoe parts is capable of replacing the conventional primer coating process with the UV radiation process. The coating pretreatment to the shoe parts can be carried out continuously in an automatic manner. Besides, creating etching effect by using UV-C radiation and ozone activating improves the bonding of the shoe parts to the adhesives, without substantial increase in equipment cost. A pretreatment system for application of coating to shoe parts can be provided with more reaction chambers for UV-C radiation and cleaning, so as to increase the breadth of application of the UV radiation system. Subjecting the surface of the shoe parts to UV-C radiation and cleaning process more than one time can activate the surface, and improve the follow-up coating quality.
    Type: Application
    Filed: May 13, 2014
    Publication date: November 19, 2015
    Applicant: ORISOL ASIA LTD.
    Inventors: Chun-Yuan CHEN, I-Lin LIN
  • Nucleic acids encoding RUP3 and methods of using same
    Patent number: 8198049
    Abstract: The invention disclosed in this patent document relates to transmembrane receptors, more particularly to endogenous, human orphan G protein-coupled receptors.
    Type: Grant
    Filed: December 2, 2010
    Date of Patent: June 12, 2012
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Ruoping Chen, Huong T. Dang, Chen W. Liaw, I-Lin Lin
  • HUMAN ORPHAN G PROTEIN-COUPLED RECEPTORS
    Publication number: 20110195431
    Abstract: The invention disclosed in this patent document relates to transmembrane receptors, more particularly to endogenous, human orphan G protein-coupled receptors.
    Type: Application
    Filed: December 2, 2010
    Publication date: August 11, 2011
    Applicant: Arena Pharmaceuticals, Inc.
    Inventors: Ruoping Chen, Huong T. Dang, Chen W. Liaw, I-Lin LIn
  • Nucleic acids encoding the GPCR, RUP3, and methods of use thereof
    Patent number: 7893235
    Abstract: The invention disclosed in this patent document relates to transmembrane receptors, more particularly to endogenous, human orphan G protein-coupled receptors.
    Type: Grant
    Filed: August 20, 2007
    Date of Patent: February 22, 2011
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Ruoping Chen, Huong T. Dang, Chen W. Liaw, I-Lin Lin
  • Human orphan G protein-coupled receptors
    Publication number: 20080199889
    Abstract: The invention disclosed in this patent document relates to transmembrane receptors, more particularly to endogenous, human orphan G protein-coupled receptors.
    Type: Application
    Filed: August 20, 2007
    Publication date: August 21, 2008
    Inventors: Ruoping Chen, Huong T. Dang, Chen W. Liaw, I-Lin Lin
  • Non-endogenous, constitutively activated known G protein-coupled receptors
    Patent number: 7381522
    Abstract: The invention disclosed in this patent document relates to transmembrane receptors, more particularly to a human G protein-coupled receptor for which the endogenous ligand is known (“known GPCRs”), and most particularly to mutated (non-endogenous) versions of the known GPCRs for use, most preferably in screening assays for the direct identification of candidate compounds as inverse agonists, agonists and partial agonists.
    Type: Grant
    Filed: April 14, 2006
    Date of Patent: June 3, 2008
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Karin Lehmann-Bruinsma, Chen W. Liaw, I-Lin Lin
  • Human orphan G protein-coupled receptors
    Publication number: 20070122878
    Abstract: The invention disclosed in this patent document relates to transmembrane receptors, more particularly to endogenous, human orphan G protein-coupled receptors.
    Type: Application
    Filed: May 4, 2006
    Publication date: May 31, 2007
    Inventors: Ruoping Chen, Huong Dang, Chen Liaw, I-Lin Lin
  • Endogenous and non-endogenous versions of human G protein-coupled receptors
    Publication number: 20060240523
    Abstract: The invention disclosed in this patent document relates to transmembrane receptors, more particularly to a human G protein-coupled receptor and to mutated (non-endogenous) versions of the human GPCRs for evidence of constitutive activity.
    Type: Application
    Filed: June 30, 2006
    Publication date: October 26, 2006
    Applicant: Arena Pharmaceuticals, Inc.
    Inventors: Chen Liaw, Derek Chalmers, Dominic Behan, Dominique Maciejewski-Lenior, James Leonard, I-Lin Lin, Daniel Ortuno
  • Endogenous and non-endogenous versions of human G protein-coupled receptors
    Patent number: 7119190
    Abstract: The invention disclosed in this patent document relates to transmembrane receptors, more particularly to a human G protein-coupled receptor and to mutated (non-endogenous) versions of the human GPCRs for evidence of constitutive activity.
    Type: Grant
    Filed: February 26, 2002
    Date of Patent: October 10, 2006
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Chen W. Liaw, Derek T. Chalmers, Dominic P. Behan, Dominique Maciejewski-Lenior, James N. Leonard, I-Lin Lin, Daniel Ortuño
  • Non-endogenous, constitutively activated known G protein-coupled receptors
    Patent number: 7097969
    Abstract: The invention disclosed in this patent document relates to transmembrane receptors, more particularly to a human G protein-coupled receptor for which the endogenous ligand is known (“known GPCRs”), and most particularly to mutated (non-endogenous) versions of the known GPCRs for use, most preferably in screening assays for the direct identification of candidate compounds as inverse agonists, agonists and partial agonists.
    Type: Grant
    Filed: August 24, 2004
    Date of Patent: August 29, 2006
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Karin Lehmann-Bruinsma, Chen W. Liaw, I-Lin Lin
  • Non-endogenous, constitutively activated known G protein-coupled receptors
    Publication number: 20060183164
    Abstract: The invention disclosed in this patent document relates to transmembrane receptors, more particularly to a human G protein-coupled receptor for which the endogenous ligand is known (“known GPCRs”), and most particularly to mutated (non-endogenous) versions of the known GPCRs for use, most preferably in screening assays for the direct identification of candidate compounds as inverse agonists, agonists and partial agonists.
    Type: Application
    Filed: April 14, 2006
    Publication date: August 17, 2006
    Applicant: Arena Pharmaceuticals, Inc.
    Inventors: Karin Lehmann-Bruinsma, Chen Liaw, I-Lin Lin
  • Non-endogenous, constitutively activated known G protein-coupled receptors
    Publication number: 20050019840
    Abstract: The invention disclosed in this patent document relates to transmembrane receptors, more particularly to a human G protein-coupled receptor for which the endogenous ligand is known (“known GPCRs”), and most particularly to mutated (non-endogenous) versions of the known GPCRs for use, most preferably in screening assays for the direct identification of candidate compounds as inverse agonists, agonists and partial agonists.
    Type: Application
    Filed: August 24, 2004
    Publication date: January 27, 2005
    Applicant: Arena Pharmaceuticals, Inc.
    Inventors: Karin Lehmann-Bruinsma, Chen Liaw, I-Lin Lin
  • Non-endogenous, constitutively activated known G protein-coupled receptors
    Patent number: 6806054
    Abstract: The invention disclosed in this patent document relates to transmembrane receptors, more particularly to a human G protein-coupled receptor for which the endogenous ligand is known (“known GPCRs”), and most particularly to mutated (non-endogenous) versions of the known GPCRs for use, most preferably in screening assays for the direct identification of candidate compounds as inverse agonists, agonists and partial agonists.
    Type: Grant
    Filed: April 5, 2001
    Date of Patent: October 19, 2004
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Karin Lehmann-Bruinsma, Chen W. Liaw, I-Lin Lin
  • Endogenous, constitutively activated G protein-coupled orphan receptors
    Publication number: 20040147429
    Abstract: Disclosed herein are techniques for directly identifying candidate compounds as agonists, partial agonists and/or, most preferably, inverse agonists, to endogenous, constitutively activated orphan G protein-coupled receptors. Such directly identified compounds can be utilized, most preferably, in pharmaceutical compositions.
    Type: Application
    Filed: September 22, 2003
    Publication date: July 29, 2004
    Applicant: Arena Pharmaceuticals, Inc.
    Inventors: Dominic P. Behan, Derek T. Chalmers, Chen W. Liaw, I-Lin Lin, Kevin P. Lowitz, Ruoping Chen
  • Nucleic acid encoding human G protein-coupled receptor
    Publication number: 20040137509
    Abstract: The invention disclosed in this patent document relates to transmembrane receptors, more particularly to endogenous, human orphan G protein-coupled receptors. The invention provides, in part, polynucleotides encoding the endogenous, human orphan G protein-coupled receptors.
    Type: Application
    Filed: February 19, 2004
    Publication date: July 15, 2004
    Inventors: Chen W. Liaw, I-Lin Lin
  • Endogenous constitutively activated G protein-coupled orphan receptors
    Patent number: 6653086
    Abstract: Disclosed herein are techniques for directly identifying candidate compounds as agonists, partial agonists and/or, most preferably, inverse agonists, to endogenous, constitutively activated orphan G protein-coupled receptors.
    Type: Grant
    Filed: July 30, 1999
    Date of Patent: November 25, 2003
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Dominic P. Behan, Derek T. Chalmers, Chen W. Liaw, I Lin-Lin, Kevin P. Lowitz, Ruoping Chen
  • Non-endogenous, constitutively activated known G protein-coupled receptors
    Publication number: 20030204073
    Abstract: The invention disclosed in this patent document relates to transmembrane receptors, more particularly to a human G protein-coupled receptor for which the endogenous ligand is known (“known GPCRs”), and most particularly to mutated (non-endogenous) versions of the known GPCRs for use, most preferably in screening assays for the direct identification of candidate compounds as inverse agonists, agonists and partial agonists.
    Type: Application
    Filed: April 5, 2001
    Publication date: October 30, 2003
    Applicant: Arena Pharmaceuticals, Inc.
    Inventors: Karin Lehmann-Bruinsma, Chen W. Liaw, I-Lin Lin
  • Human orphan G protein-coupled receptors
    Publication number: 20030175891
    Abstract: The invention disclosed in this patent document relates to transmembrane receptors, more particularly to endogenous, human orphan G protein-coupled receptors.
    Type: Application
    Filed: March 21, 2003
    Publication date: September 18, 2003
    Inventors: Ruoping Chen, Huong T. Dang, Chen W. Liaw, I-Lin Lin
  • Human orphan G protein-coupled receptors
    Publication number: 20030148450
    Abstract: The invention disclosed in this patent document relates to transmembrane receptors, more particularly to endogenous, human orphan G protein-coupled receptors.
    Type: Application
    Filed: October 17, 2002
    Publication date: August 7, 2003
    Inventors: Ruoping Chen, Huong T. Dang, Chen W. Liaw, I-Lin Lin
  • Endogenous and non-endogenous versions of human G protein-coupled receptors
    Publication number: 20030023069
    Abstract: The invention disclosed in this patent document relates to transmembrane receptors, more particularly to a human G protein-coupled receptor and to mutated (non-endogenous) versions of the human GPCRs for evidence of constitutive activity.
    Type: Application
    Filed: February 26, 2002
    Publication date: January 30, 2003
    Inventors: Chen W. Liaw, Derek T. Chalmers, Dominic P. Behan, Dominique Maciejewski-Lenior, James N. Leonard, I-Lin Lin, Daniel Ortuno